CELU Stock Summary and Trading Ideas (Celularity - Class A | NASDAQ:CELU)

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

Celularity - Class A trades on the NASDAQ stock market under the symbol CELU.

As of June 3, 2026, CELU stock price declined to $1.02 with 149,526 million shares trading.

CELU has a beta of 0.85, meaning it tends to be less sensitive to market movements. CELU has a correlation of 0.01 to the broad based SPY ETF.

CELU has a market cap of $29.05 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, CELU traded as high as $8.90 and as low as $.71.

The top ETF exchange traded funds that CELU belongs to (by Net Assets): VTI, VXF, IWC.

CELU has underperformed the market in the last year with a return of -54.5%, while the SPY ETF gained +28.5%. In the last 3 month period, CELU fell short of the market, returning -15.0%, while SPY returned +10.1%. However, in the most recent 2 weeks CELU has outperformed the stock market by returning +26.5%, while SPY returned +2.8%.

CELU support price is $1.00 and resistance is $1.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CELU shares will trade within this expected range on the day.